Innoviva
(NASDAQ) INVA
Innoviva Financials at a Glance
Market Cap
$1.66B
Revenue (TTM)
$424.12M
Net Income (TTM)
$504.34M
EPS (TTM)
$6.01
P/E Ratio
3.73
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$22.46
Volume
1,187,326.151
Open
$22.17
Price
$22.46
Volume
1,187,326.151
Open
$22.17
Previous Close
$22.46
Daily Range
$21.95 - $22.50
52-Week Range
$16.52 - $25.14
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$22.46
Volume
1,187,326.151
Open
$22.17
Previous Close
$22.46
Daily Range
$21.95 - $22.50
52-Week Range
$16.52 - $25.14
INVA News
INVA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Innoviva
Industry
Pharmaceuticals
Sector
Health CareEmployees
159
CEO
Pavel Raifeld, CFA, MBA
Website
www.inva.comHeadquarters
Burlingame, CA 94010, US
INVA Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
15%
Net Income Margin
1%
Return on Equity
51%
Return on Capital
3%
Return on Assets
27%
Earnings Yield
26.81%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.66B
Shares Outstanding
73.81M
Volume
1.19M
Avg. Volume
730.12K
Financials (TTM)
Gross Profit
$307.52M
Operating Income
$163.75M
EBITDA
$383.79M
Operating Cash Flow
$196.93M
Capital Expenditure
$1.13M
Free Cash Flow
$195.80M
Cash & ST Invst.
$550.94M
Total Debt
$269.02M
Innoviva Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$97.99M
+10.6%
Gross Profit
$75.83M
-5.0%
Gross Margin
77.39%
N/A
Market Cap
$1.66B
N/A
Market Cap/Employee
$13.05M
N/A
Employees
127
N/A
Net Income
$186.59M
+500.6%
EBITDA
$48.20M
+275.9%
Quarterly Fundamentals
Net Cash
$280.51M
+6510.3%
Accounts Receivable
$92.63M
+18.9%
Inventory
$38.84M
-6.4%
Long Term Debt
$326.08M
+26.5%
Short Term Debt
$5.34M
-97.2%
Return on Assets
27.46%
N/A
Return on Invested Capital
3.50%
N/A
Free Cash Flow
$34.79M
-28.4%
Operating Cash Flow
$35.28M
-27.4%